HomeCHRS • NASDAQ
add
Coherus Biosciences Inc
Previous close
$0.82
Day range
$0.77 - $0.86
Year range
$0.66 - $3.70
Market cap
93.89M USD
Avg Volume
2.84M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 64.98M | 10.67% |
Operating expense | 57.12M | -16.50% |
Net income | -12.92M | 69.86% |
Net profit margin | -19.88 | 72.77% |
Earnings per share | -0.14 | 63.16% |
EBITDA | -19.32M | 42.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 159.24M | 10.04% |
Total assets | 674.86M | 43.71% |
Total liabilities | 758.96M | 17.79% |
Total equity | -84.11M | — |
Shares outstanding | 115.21M | — |
Price to book | -1.12 | — |
Return on assets | -7.13% | — |
Return on capital | -17.53% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -12.92M | 69.86% |
Cash from operations | 59.73M | 253.50% |
Cash from investing | 27.66M | -33.14% |
Cash from financing | -187.92M | -445.93% |
Net change in cash | -100.54M | -277.08% |
Free cash flow | 61.35M | 358.24% |
About
Founded
2010
Headquarters
Website
Employees
235
